# Neumora Therapeutics, Inc.: filings

NMRA · Nasdaq · CIK 1885522 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nmra.md) · [Financials](/companies/nmra/financials.md) · [Filings](/companies/nmra/filings.md) · [Insiders](/companies/nmra/insiders.md)

## Reports and events: 56 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 100, 8-K 32, 144 26, 3 16, 10-Q 9, DRS/A 8, UPLOAD 7, DRSLTR 6, SCHEDULE 13G/A 5, DEFA14A 4, S-8 4, SCHEDULE 13G 4, 10-K 3, CORRESP 3, DEF 14A 3, 8-K/A 2, EFFECT 2, SC 13D/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, POS AM 1, POSASR 1, PRE 14A 1, S-1 1, S-1/A 1, S-3ASR 1, SC 13D 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:05 ET | [8-K](/filings/0001193125-26-441634.md) | 3.01 Delisting notice | 0001193125-26-441634 |
| 2026-08-14 | 07:23 ET | [10-Q](/filings/0001193125-26-350370.md) | Quarterly report, period 2026-06-30 | 0001193125-26-350370 |
| 2026-08-14 | 07:13 ET | [8-K](/filings/0001193125-26-350349.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-350349 |
| 2026-07-27 | 07:07 ET | [8-K](/filings/0001193125-26-316819.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316819 |
| 2026-06-15 | 08:15 ET | [8-K](/filings/0001193125-26-270328.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270328 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0001193125-26-248244.md) | 5.07 Shareholder vote results | 0001193125-26-248244 |
| 2026-05-07 | 16:01 ET | [10-Q](/filings/0001193125-26-211825.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211825 |
| 2026-05-07 | 07:10 ET | [8-K](/filings/0001193125-26-210310.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210310 |
| 2026-04-17 | 16:04 ET | [DEF 14A](/filings/0001193125-26-161489.md) | Proxy statement, period 2026-05-27 | 0001193125-26-161489 |
| 2026-04-01 | 16:10 ET | [SCHEDULE 13D/A](/filings/0001012975-26-000294.md) | Ownership report, active investor, amended | 0001012975-26-000294 |
| 2026-03-30 | 07:07 ET | [10-K](/filings/0001193125-26-130388.md) | Annual report, period 2025-12-31 | 0001193125-26-130388 |
| 2026-03-30 | 06:58 ET | [8-K](/filings/0001193125-26-130372.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-130372 |
| 2026-02-11 | 07:00 ET | [8-K](/filings/0001193125-26-045526.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045526 |
| 2026-01-12 | 07:00 ET | [8-K](/filings/0001193125-26-009727.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009727 |
| 2026-01-05 | 06:44 ET | [8-K](/filings/0001193125-26-001472.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-001472 |
| 2025-11-21 | 16:05 ET | [8-K](/filings/0001193125-25-291352.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-291352 |
| 2025-11-06 | 16:02 ET | [10-Q](/filings/0001193125-25-269446.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269446 |
| 2025-11-06 | 07:05 ET | [8-K](/filings/0001193125-25-268046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268046 |
| 2025-10-29 | 19:07 ET | [SCHEDULE 13D/A](/filings/0001012975-25-000675.md) | Ownership report, active investor, amended | 0001012975-25-000675 |
| 2025-10-27 | 07:02 ET | [8-K](/filings/0001193125-25-250677.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250677 |
| 2025-10-27 | 06:34 ET | [8-K](/filings/0001193125-25-250656.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250656 |
| 2025-08-06 | 16:31 ET | [10-Q](/filings/0000950170-25-104138.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104138 |
| 2025-08-06 | 16:07 ET | [8-K](/filings/0000950170-25-103997.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103997 |
| 2025-05-30 | 17:21 ET | [8-K](/filings/0001193125-25-132307.md) | 5.07 Shareholder vote results | 0001193125-25-132307 |
| 2025-05-16 | 16:26 ET | [8-K](/filings/0001193125-25-121714.md) | 3.01 Delisting notice | 0001193125-25-121714 |
| 2025-05-12 | 16:33 ET | [10-Q](/filings/0000950170-25-069311.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069311 |
| 2025-05-12 | 16:04 ET | [8-K](/filings/0000950170-25-069147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069147 |
| 2025-04-29 | 16:03 ET | [DEF 14A](/filings/0000950170-25-060084.md) | Proxy statement, period 2025-05-28 | 0000950170-25-060084 |
| 2025-04-11 | 16:34 ET | [8-K/A](/filings/0000950170-25-053303.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-053303 |
| 2025-03-03 | 07:32 ET | [10-K](/filings/0000950170-25-030401.md) | Annual report, period 2024-12-31 | 0000950170-25-030401 |
| 2025-03-03 | 07:06 ET | [8-K](/filings/0000950170-25-030396.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-030396 |
| 2025-02-21 | 16:01 ET | [8-K/A](/filings/0001193125-25-031974.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-031974 |
| 2025-02-13 | 16:51 ET | [8-K](/filings/0001193125-25-026156.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-026156 |
| 2025-01-13 | 08:00 ET | [8-K](/filings/0001193125-25-004999.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004999 |
| 2025-01-02 | 07:10 ET | [8-K](/filings/0001193125-25-000084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-000084 |
| 2024-11-22 | 17:33 ET | [SC 13D/A](/filings/0001072613-24-000899.md) | Ownership report, active investor, amended | 0001072613-24-000899 |
| 2024-11-12 | 16:15 ET | [10-Q](/filings/0000950170-24-125437.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125437 |
| 2024-11-12 | 07:17 ET | [8-K](/filings/0000950170-24-124563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124563 |
| 2024-08-06 | 16:02 ET | [10-Q](/filings/0000950170-24-091737.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091737 |
| 2024-08-06 | 07:15 ET | [8-K](/filings/0000950170-24-091205.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091205 |
| 2024-06-14 | 16:01 ET | [8-K](/filings/0001193125-24-161572.md) | 5.07 Shareholder vote results | 0001193125-24-161572 |
| 2024-05-07 | 16:01 ET | [10-Q](/filings/0000950170-24-054448.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054448 |
| 2024-05-07 | 07:15 ET | [8-K](/filings/0000950170-24-053933.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053933 |
| 2024-04-25 | 16:05 ET | [DEF 14A](/filings/0000950170-24-048287.md) | Proxy statement, period 2024-06-13 | 0000950170-24-048287 |
| 2024-04-15 | 06:46 ET | [8-K](/filings/0001193125-24-095472.md) | 8.01 Other events | 0001193125-24-095472 |
| 2024-03-07 | 16:05 ET | [10-K](/filings/0000950170-24-027927.md) | Annual report, period 2023-12-31 | 0000950170-24-027927 |
| 2024-03-07 | 07:08 ET | [8-K](/filings/0001193125-24-061473.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-061473 |
| 2024-01-08 | 08:32 ET | [8-K](/filings/0001193125-24-003968.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003968 |
| 2023-12-15 | 17:06 ET | [SC 13D/A](/filings/0001072613-23-000627.md) | Ownership report, active investor, amended | 0001072613-23-000627 |
| 2023-11-28 | 16:21 ET | [8-K](/filings/0001193125-23-284303.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-284303 |

Page 1 of 2. [Older](/companies/nmra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.